Multicenter, prospective and observational Trial. Percutaneous Coronary Intervention with the ANgiolite: an Optical CoHerence TOmogRaphy Study. 6 months outcomes. Published at Catheter Cardiovasc Interv. 2017;1-9.
DESCRIPTION
Device
Angiolite
Number of patients
103
Follow up
24 month
Type of lesions
De-novo lesions
OUTCOMES
Primary endpoints
Strut coverage at 3 months
Secondary endpoints
0.07%
In-stent
Late Lumen Loss
0%
Stent
Thrombosis
1%
Target
Lesion Failure
Rodés-Cabau J. Catheter Cardiovasc. Interv. 2018;91:435–443. 2 years clinical outcomes presented in TCT 2019
CONCLUSIONS
“These low rates are demonstrating an excellent stent performance”
In ANCHOR, Angiolite demonstrated a favorable early healing profile assessed with OCT at 3 and 6-month post PCI.
This was characterized by high rates of strut coverage and very low rates of in-stent LLL.
Imaging data were also coupled with favorable 24-month clinical data characterized by the absence of binary in-stent restenosis, stent thrombosis, myocardial infarction or cardiac death, suggesting a highly efficacy of Angiolite.
MAIN INVESTIGATOR
Dr. Josep Rodés-Cabau (PI)
Quebec Heart and Lung Institute (Quebec, CAN)
